Prenatal Magnetic Resonance Imaging, Ultrasound Imaging Findings and Genetic Analysis of Concomitant Rhabdomyomas and Cerebral Tuberous Sclerosis  by Chen, Chih-Ping et al.
Taiwan J Obstet Gynecol • September 2009 • Vol 48 • No 3 327
■ RESEARCH LETTER ■
A 32-year-old, gravida 3, para 1, woman had an uncom-
plicated pregnancy until 29 weeks’ gestation when mul-
tiple fetal cardiac tumors were detected on routine
ultrasound. She had experienced one abortion. Her first
child was a 3-year-old healthy boy. This was her third
pregnancy. She and her husband were healthy and did
not have any family history of tuberous sclerosis complex
(TSC) or cardiac tumors. Detailed sonographic exami-
nation of the fetal heart demonstrated seven cardiac
rhabdomyomas including a 0.89 × 0.44 cm tumor in the
lowest part of the interventricular septum (IVS) near 
the apex, a 0.84×0.64 cm tumor in the upper part of the
IVS near the crus, a 0.34 × 0.20 cm tumor in the middle
part of the IVS, two tumors measuring 0.37 × 0.30 cm
and 0.30×0.18 cm in the lateral wall of the left ventricle,
a 0.49 × 0.33 cm tumor in the lateral wall of the left
ventricle near the aortic valve, and a 0.35 × 0.24 cm
tumor in the lateral wall of the left atrium (Figure 1).
Detailed sonographic examination of the fetal brain also
demonstrated several suspicious echogenic foci around
the cerebral ventricles (Figure 2). Ultrafast magnetic res-
onance imaging (MRI) revealed small subependymal
tubers (Figure 3) and cardiac rhabdomyomas (Figure 4).
Cordocentesis revealed a karyotype of 46,XX and a 
de novo frameshift mutation to the TSC2 gene or TSC2
exon 33 c.4420_4421delAG (Figure 5). DNA analysis
of the parents did not show the mutation. The woman 
had intrauterine fetal death at 30 weeks of gestation.
A 1,376-g dead fetus was delivered vaginally.
The present fetus had multiple cardiac rhabdomy-
omas and cerebral tuberous sclerosis, and was associ-
ated with a frameshift mutation in the TSC2 gene. 
Józ´wiak and Kotulska [1] suggested that prenatally
diagnosed multiple cardiac rhabdomyomas are a sign
of TSC because cardiac rhabdomyomas are the earliest
and most frequently reported sign of TSC in the fetuses.
Józ´wiak et al [2] found that cardiac rhabdomyomas
were diagnosed in 83.3% (20/24) of TSC children under
2 years of age, in 21.4% (3/14) of the TSC children at
2–5 years of age, and in 21.1% (4/19) of TSC children at
5–9 years of age. Tworetzky et al [3] found that TSC was
diagnosed in 95.3% (61/64) of fetuses and neonates
with multiple cardiac tumors and in 23.3% (7/30) of
patients with a single cardiac tumor. Tworetzky et al [3]
also found that multiple cardiac tumors were signifi-
cantly more likely to have TSC than in patients with a sin-
gle tumor (relative risk, RR, 4.1; 95% confidence interval,
CI, 2.1–7.8; p <0.001) or in patients with a single ventric-
ular tumor (RR, 3.1; 95% CI, 1.7–5.8; p < 0.001). With
the advent of MRI technology, prenatal MRI has been
shown to be a useful adjunct to ultrasound for the pre-
cise determination of the extent of cerebral involvement
of TSC. Mirlesse et al [4] first reported the use of prena-
tal MRI in the evaluation of fetal cerebral tuberous scle-
rosis. Kivelitz et al [5] first described the use of prenatal
MRI in the evaluation of fetal cardiac rhabdomyomas.
Chen et al [6] first reported the prenatal MRI demon-
stration of concomitant fetal cardiac rhabdomyomas
and cerebral tuberous sclerosis. The present case shows
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that prenatal MRI is particularly useful for the confir-
mation of the cerebral tuberous sclerosis lesions when
prenatal ultrasound reveals suspicious cerebral lesions.
Symptomatic rhabdomyomas may present poor prog-
nosis. Kagan et al [7] reported ventricular outflow ob-
struction, valve aplasia, bradyarrhythmia, pulmonary
hypoplasia, hydrops fetalis, and fetal death of a fetus
with a large rhabdomyoma and unknown tuberous scle-
rosis at 32 weeks of gestation. Lin et al [8] reported
intrauterine fetal death of a fetus with intrauterine
rhabdomyomas at 30 weeks of gestation.
TSC is caused by mutations of the tumor suppressor
genes, TSC1 and TSC2. The TSC1 gene (OMIM 605284)
is mapped to chromosome 9q34 and encodes the pro-
tein hamartin [9]. The TSC2 gene (OMIM 191092) is
mapped to chromosome 16p13.3 and encodes the pro-
tein tuberin [10,11]. In a mutation analysis of the TSC1
and TSC2 genes in 84 Taiwanese TSC families, Hung et al
[12] identified mutations in 76.2% (64/84) of the cases,
including nine TSC1 mutations (seven sporadic and two
familial) and 55 TSC2 mutations (47 sporadic and eight
familial), and found that diseases resulting from the
Taiwan J Obstet Gynecol • September 2009 • Vol 48 • No 3328
C.P. Chen, et al
Figure 1. Prenatal ultrasound of the heart at 29 weeks’ gestation shows: (A) a 0.89 × 0.44 cm tumor in the lowest part of 
the interventricular septum (IVS) near the apex, (B) a 0.84 × 0.64 cm tumor in the upper part of the IVS near the crus, 
(C) a 0.34 × 0.20 cm tumor in the middle part of the IVS, (D) a 0.37 × 0.30 cm tumors in the lateral wall of the left ventricle,
(E) a 0.30 × 0.18 cm tumor in the lateral wall of the left ventricle, and (F) a 0.49 × 0.33 cm tumor in the lateral wall of the left 
ventricle near the aortic valve.
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Figure 2. (A–E) Prenatal ultrasound of the brain at 29 weeks’
gestation shows multiple echogenic foci (arrows).
Figure 3. (A, B) Ultrafast magnetic resonance imaging of the brain reveals small subependymal tubers (arrows).
A B
Taiwan J Obstet Gynecol • September 2009 • Vol 48 • No 3330
C.P. Chen, et al
TSC1 mutations were less severe than those with the
TSC2 mutations. In the clinical and genotype studies
of cardiac tumors in patients with TSC, Józ´wiak et al
[13] found that mutations in the TSC1 and TSC2 genes
were detected in 85% (108/127) of the cases, with car-
diac rhabdomyomas being more frequent in the TSC2
group (50/93; 53.8%) than in the TSC1 group (3/15;
20%), with clinical manifestations being more severe in
the TSC2 group than in the TSC1 group. Prenatal diag-
nosis of rhabdomyomas should prompt molecular
genetic analysis of the TSC1 and TSC2 genes of the index
fetuses and the parents to exclude polymorphism and
familial inheritance [14–17]. With the advent of mod-
ern molecular technology, prenatal molecular diagnosis
of TSC is possible. Milunsky et al [17] reported suc-
cessful DNA analysis of the TSC genes in 96% (48/50) of
the tested fetuses. The present case had a frameshift
mutation in TSC2 exon 33 and was associated with de
novo deletions. Frameshift mutations in TSC2 exon 33 as
a result of deletions have been documented in Chinese
patients [12,18], and exon 33 in the TSC2 gene is a hot
spot of mutations in the Chinese population.
In conclusion, we have presented the prenatal ultra-
sound, MRI findings and molecular analysis of concomi-
tant rhabdomyomas and cerebral tuberous sclerosis.
We suggest that tuberous sclerosis should be sus-
pected in all fetuses with prenatally diagnosed cardiac
rhabdomyomas.
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